| Sign In to gain access to subscriptions and/or personal tools. |
Amisulpride poisoning: a report on two casesInstitut de Médecine Légale, Faculté de Médecine de Strasbourg, 11 rue Humann, 67085 Strasbourg
Département d'Anesthésiologie, CHRU / Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg
Institut de Médecine Légale, Faculté de Médecine de Strasbourg, 11 rue Humann, 67085 Strasbourg
Service de Réanimation Médicale et Centre Anti-Poisons, Pavillon Pasteur, CHRU / Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg Cedex, France
Institut de Médecine Légale, Faculté de Médecine de Strasbourg, 11 rue Humann, 67085 Strasbourg The first two observations of human poisoning involving the recently developed neuroleptic amisulpride are described. In both cases drug determination was per formed using reversed-phase HPLC coupled with diode- array detection. Case 1 was a nonfatal overdosage in which the ingestion of 3.0 g amisulpride induced an attack of seizures, then light coma with agitation, hyperthermia, mydriasis, minimal extrapyramidal features, tachycardia and slight prolongation of the QT interval; the blood con centration of amisulpride was 9.63 µg ml-1. Case 2 was a fatality attributed to amisulpride in which the measured blood concentration was 41.70 µg ml-1. Our results are discussed in the light of data previously reported on the toxicity of substituted benzamides.
Key Words: amisulpride neuroleptic poisoning toxicology liquid chromatography
Human & Experimental Toxicology, Vol. 14, No. 3,
294-298 (1995) This article has been cited by other articles:
|
|||||||||||||||
